2 tracked superinvestors hold NUVATION BIO INC (NUVB), worth $26M combined, led by Stanley Druckenmiller. Smart money is holding NUVB as of the latest 13F filings.
Current price
$6.81
+99.1%
1Y
Nuvation Bio Inc. functions as a clinical-stage biopharmaceutical enterprise committed to discovering and advancing therapeutic solutions for oncological conditions. Its foremost experimental compound, NUV-422, is a small molecule designed to inhibit cyclin-dependent kinases (CDK)2, CDK4, and CDK6. The company's development pipeline further encompasses NUV-868, an orally administered, selective…
Market cap
$1.6B
P/E
-7.48
Div yield
0.0%
Revenue YoY
699.0%
Analyst target
$21
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
2
tracked 13F / N-PORT funds
Combined value
$26M
disclosed long exposure
Tier-1 conviction
2
concentrated holders
Net this quarter
0
0 buying · 0 selling
Smart money is holding NUVB steady this quarter — buys and sells are balanced.
NUVATION BIO INC (NUVB) is held by 2 tracked funds worth $26M combined, 2 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Stanley Druckenmiller at 0.5% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
Tracked holders were largely static this quarter — no new opens, adds or trims of size — suggesting the position is being held rather than actively traded.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Held | 0.5% | $26M | |
| Held | 0% | $199K |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
2 insiders filed SEC Form 144 for $1M of proposed sales in the last 90 days. A 144 is filed before the trade — see who else is selling.
| Insider | Role | Shares | Value | Filed |
|---|---|---|---|---|
| Gary Hattersley | Officer | 100,000 | $696K | 2026-08-19 |
| Stacy Markel | Officer | 125,000 | $720K | 2026-06-23 |
Which superinvestors own NUVB?
2 tracked funds hold NUVATION BIO INC (NUVB), the largest being Stanley Druckenmiller (Duquesne Family Office) at 0.5% of its 13F portfolio. 2 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling NUVB?
In the most recent 13F quarter, 0 tracked funds added or opened NUVB and 0 trimmed it.
How much NUVB do tracked funds hold?
Combined disclosed long exposure to NUVB across tracked superinvestors is $26M as of the Jun 2026 filings.
One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.